Literature DB >> 27258970

The Transcriptional Regulation of FOXO Genes in Thyrocytes.

F Franz1, C Weidinger1, K Krause1, O Gimm2, H Dralle2, D Führer3.   

Abstract

FOXO transcription factors are key regulators of DNA damage repair, proliferation and apoptosis in thyrocytes. Thyroid malignancies show impaired FOXO function. In this study, we investigated the transcriptional regulation of FOXO isoforms in thyroid epithelial cells. mRNA expression of FOXO isoforms (FOXO1, 3 and 4) was determined in FRTL-5 cells stimulated with different growth factors and H2O2. Furthermore, the impact of PI3K/AKT signalling on FOXO transcription was investigated in PI3K p110α mutant FRTL-5 cells and regulatory dependence of FOXO transcription on FOXO was studied in FRTL-5 cells with hFOXO3 overexpression. Finally, mRNA expression levels of FOXO isoforms were determined in human epithelial thyroid tumours. Growth factor deprivation induced transcription of FOXO1, 3 and 4, whereas insulin stimulation decreased FOXO1 and FOXO4 transcription in FRTL-5 cells. Inhibition of the PI3K/AKT cascade amplified FOXO1 and FOXO4 expression. In contrast, H2O2 and TSH did not influence FOXO transcription in thyrocytes. Overexpression of PI3K p110α inhibited FOXO3 and induced FOXO4 transcription. In human thyroid tumours, FOXO1 and FOXO3 mRNA levels were significantly downregulated in papillary thyroid carcinoma when compared to normal tissues. In contrast, follicular thyroid carcinomas showed significant upregulation of FOXO4 mRNA.In this paper, we demonstrate an influence of PI3K signalling on FOXO transcription in thyrocytes. Moreover, we show that thyroid cancers exhibit alterations in FOXO transcription besides the previously reported alterations in posttranslational FOXO3 regulation. These findings may add to the concept of targeting the PI3K pathway in advanced thyroid cancers. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27258970     DOI: 10.1055/s-0042-105153

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

1.  Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells.

Authors:  Valentina Maggisano; Francesca Capriglione; Antonella Verrienti; Marilena Celano; Agnese Gagliardi; Stefania Bulotta; Marialuisa Sponziello; Catia Mio; Valeria Pecce; Cosimo Durante; Giuseppe Damante; Diego Russo
Journal:  Biomedicines       Date:  2022-04-21

2.  DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid Cancers.

Authors:  Mahsa Javid; Thanyawat Sasanakietkul; Norman G Nicolson; Courtney E Gibson; Glenda G Callender; Reju Korah; Tobias Carling
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

Review 3.  Current perspective on the regulation of FOXO4 and its role in disease progression.

Authors:  Wen Liu; Yong Li; Bing Luo
Journal:  Cell Mol Life Sci       Date:  2019-09-16       Impact factor: 9.261

4.  Overcoming EZH2 Inhibitor Resistance by Taxane in PTEN-Mutated Cancer.

Authors:  Linlin Ma; Yuqian Yan; Yang Bai; Yinhui Yang; Yunqian Pan; Xiaokun Gang; R Jeffrey Karnes; Jun Zhang; Qiubo Lv; Qiang Wu; Haojie Huang
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

5.  Resveratrol inhibits bile acid-induced gastric intestinal metaplasia via the PI3K/AKT/p-FoxO4 signalling pathway.

Authors:  Wenquan Lu; Zhen Ni; Shuqin Jiang; Mingfu Tong; Jian Zhang; Jing Zhao; Chenchen Feng; Qiaoyu Jia; Jingyun Wang; Tingting Yao; Hanbing Ning; Yongquan Shi
Journal:  Phytother Res       Date:  2020-10-25       Impact factor: 5.878

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.